These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6158065)

  • 1. Changes in endorphins and 5-hydroxyindoleacetic acid in cerebrospinal fluid as a result of treatment with a serotonin reuptake inhibitor (zimelidine) in chronic pain patients.
    Johansson F; von Knorring L; Sedvall G; Terenius L
    Psychiatry Res; 1980 May; 2(2):167-72. PubMed ID: 6158065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
    Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the augmenter-reducer tendency and in pain measures as a result of treatment with a serotonin-reuptake inhibitor--zimelidine.
    von Knorring L; Johansson F
    Neuropsychobiology; 1980; 6(6):313-8. PubMed ID: 6449679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual evoked potentials as a predictor of reported side effects during a trial of zimelidine vs. placebo in chronic pain patients.
    von Knorring L; Johansson F
    Psychiatry Res; 1979 Dec; 1(3):225-30. PubMed ID: 298350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical effects of zimelidine in man.
    Bertilsson L; Tuck JR; Siwers B
    Eur J Clin Pharmacol; 1980 Nov; 18(6):483-7. PubMed ID: 6450684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat.
    Ross SB; Hall H; Renyi AL; Westerlund D
    Psychopharmacology (Berl); 1981; 72(3):219-25. PubMed ID: 6164072
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative pharmacokinetics of zimelidine and desipramine in man following acute and chronic administration.
    Potter WZ; Calil HM; Extein I; Zavadil AP; Goodwin FK
    Psychiatry Res; 1979 Dec; 1(3):273-81. PubMed ID: 298355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of beta-endorphin in pain in cancer patients].
    González-Navarro A; Zimman Mansfeld H; Molinero Aparicio T; González Hernandez MJ; González Maté A; Borque-Ibarra M
    Vopr Onkol; 1987; 33(7):26-32. PubMed ID: 2441526
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind comparisons of a selective serotonin reuptake inhibitor, zimelidine, and placebo on quantified EEG parameters and psychological variables.
    Schenk GK; Filler W; Ranft W; Zerbin D
    Acta Psychiatr Scand Suppl; 1981; 290():303-13. PubMed ID: 6452797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vigilance behavior in interaction of the serotonin-selective antidepressant zimelidine and parenterally administered ethanol].
    Schaffler K; Arnold H; Hörmann E
    Arzneimittelforschung; 1982; 32(8):845-52. PubMed ID: 6215927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of pethidine-induced antinociception by zimelidine, an inhibitor of 5-hydroxytryptamine reuptake.
    Gebhart GF; Lorens SA
    Br J Pharmacol; 1980 Nov; 70(3):411-4. PubMed ID: 6449224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [beta-Endorphin and monoamine metabolite concentrations in patients with intractable pain--changes before and after deep brain or spinal dorsal column stimulation].
    Namba S; Fujiwara N; Namba Y; Nishimoto A
    No To Shinkei; 1985 Aug; 37(8):775-83. PubMed ID: 2416330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of zimelidine, a new antidepressant, on appetite and body weight.
    Simpson RJ; Lawton DJ; Watt MH; Tiplady B
    Br J Clin Pharmacol; 1981 Jan; 11(1):96-8. PubMed ID: 6452151
    [No Abstract]   [Full Text] [Related]  

  • 16. Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia.
    Ogren SO; Holm AC
    J Neural Transm; 1980; 47(4):253-71. PubMed ID: 6446594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of voluntary morphine consumption following treatment with zimelidine.
    Rockman GE; Amit Z; Bourque C; Brown ZW; Ogren SO
    Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):123-9. PubMed ID: 6448029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of zimelidine on various transmitter systems in the brain.
    Hall H; Ross SB; Ogren SO
    Adv Biochem Psychopharmacol; 1982; 31():321-5. PubMed ID: 6282061
    [No Abstract]   [Full Text] [Related]  

  • 19. Qualitative changes in saliva composition after short-term administration of imipramine and zimelidine in healthy volunteers.
    von Knorring L; Mörnstad H
    Scand J Dent Res; 1981 Aug; 89(4):313-20. PubMed ID: 6458872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat.
    Blier P; De Montigny C
    J Neurosci; 1983 Jun; 3(6):1270-8. PubMed ID: 6304261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.